Alphabet-backed start-up Isomorphic Labs has added to the lustre attached to its AI-powered drug discovery engine by raising ...

Novo Nordisk has been handed a crucial legal win by China's Supreme Court, which has upheld the company's patent protection on GLP-1 agonist semaglutide used for diabetes and weight loss. The court in ...

Dr. Martin Makary has resigned from the FDA rather than be let go, according to multiple media reports citing unnamed ...

Bristol Myers Squibb has forged close ties with China's Hengrui Pharma, partnering across 13 programmes in oncology, haematology, and immunology in a deal that could be worth a massive $15.2 billion.

Lawmakers in the EU have reached a provisional agreement to strengthen the bloc's critical medicine supply chain and avert the risk of shortages amid rising geopolitical tensions. The Critical ...

Novo Nordisk has sold the rights to one of the flagship candidates in its now-defunct cell therapy unit, which was wound down ...

Novo Nordisk has identified a group of early responders to its high-dose Wegovy formulation that shed almost 28% of their weight in its flagship STEP UP trial. The new analysis, presented at the ...

Roche has been working with US AI specialist PathAI for around five years, and has now upgraded that partnership with an offer to buy the company outright for $1.05 billion. Already a giant in the ...

Bayer has agreed terms for its first biopharma acquisition in years, paying $300 million upfront for privately-held US biotech Perfuse Therapeutic and its novel drug implant for eye diseases. The deal ...

Having already committed last year to capital investments of $27 billion in the US to ward off the threat of tariffs, Eli Lilly has upped the ante. The Indianapolis-headquartered pharma group pledged ...

There is little doubt that the biopharma sector is undergoing unprecedented levels of change right now. Its global supply chain is in a state of great change due to geopolitical and economic drivers, ...

The lengthy appraisal – which has extended for almost two years – was delayed while Italfarmaco subsidiary ITF Pharma and NHS ...